COMMUNIQUÉS West-GlobeNewswire

HX GLOBAL SECURITY VP CONTINUES EPIC SOLO ROW ACROSS ATLANTIC

24/01/2019 - 21:00

Tim Crockett toughs out knee injury and sits in second place on marathon row to support veterans’ mental health BOSTON, Jan. 24, 2019 (GLOBE NEWSWIRE) -- BOSTON Jan. 24, 2019 – Tim Crockett, Vice President of Security [...]

SuperSonic Imagine Installs 13 Aixplorer MACH® 30 Systems in Israel

24/01/2019 - 18:00

Sale and installation of 13 Aixplorer MACH® 30 ultrasound systems in the Clalit network: leader of Israeli health insurance organisation Use of ultrasound systems in senology, gastroenterology and mainstream medicine [...]

SuperSonic Imagine installe 13 Aixplorer MACH® 30 en Israël

24/01/2019 - 18:00

Vente et installation de 13 Aixplorer MACH® 30 dans le réseau Clalit : leader israëlien de la Caisse d’Assurance Santé. Utilisation des échographes en sénologie, gastro-entérologie et médecine courante en imagerie [...]

REPEAT - Hemispherx Biopharma’s CEO to Present at the 15th Annual NobleConXV Conference

24/01/2019 - 17:59

OCALA, Fla., Jan. 24, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, announced [...]

Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress

24/01/2019 - 17:45

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNalpha KINOID CLINICAL STUDY AT THE 13 TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019) 5 - 9 APRIL, SAN FRANCISCO Paris [...]

Néovacs présentera les résultats complets de l'étude clinique de Phase IIb avec l'IFNalpha Kinoïde au 13th International Lupus Congress

24/01/2019 - 17:45

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTERA LES RÉSULTATS COMPLETS DE L’ÉTUDE CLINIQUE DE PHASE IIb AVEC l’IFNα Kinoïde AU 13 TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019) 5 - 9 [...]

Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

24/01/2019 - 16:00

CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for [...]

ATW Tech Announces Appointment on its Management Team

24/01/2019 - 15:00

MONTREAL, Jan. 24, 2019 (GLOBE NEWSWIRE) -- The Founder, President and Chief Executive Officer of ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW), Mr. Michel Guay, is pleased to announce the appointment of Mr. Denis LP [...]

ATW Tech annonce une nomination à son équipe de direction

24/01/2019 - 15:00

MONTRÉAL, 24 janv. 2019 (GLOBE NEWSWIRE) -- Le fondateur, président et chef de la direction d’ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), M. Michel Guay, est heureux d’annoncer la nomination de M. Denis LP Archambault [...]

Generex Subsidiary NuGenerex Diagnostics Announces CE-Mark Certification for its Rapid Point-of-Care Express II Syphilis Treponemal Assay

24/01/2019 - 15:00

-- Rapid point-of-care syphilis assay -- Cleared for sale in the European Union -- Addressing the emerging global syphilis resurgence MIRAMAR, FL, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NuGenerex [...]

Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares

24/01/2019 - 14:48

CAMBRIDGE, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, genetically-defined [...]

Arch Biopartners Arranges Convertible Note Financing

24/01/2019 - 14:43

TORONTO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing [...]

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Ointment USP, 0.05%

24/01/2019 - 14:30

BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorization (CMA) Application for ANCA-Associated Vasculitis in Europe; Phase III ADVOCATE Trial Data Release Planned for Q4 2019

24/01/2019 - 14:30

-- Companies plan to file for full marketing approval to EMA and FDA in 2020 -- MOUNTAIN VIEW, Calif. and ZURICH, Switzerland, Jan. 24, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal [...]

CFN Media's Exclusive Executive Interview With Grown Rogue on Michigan Expansion

24/01/2019 - 14:30

Seattle, Washington, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]

Kane Biotech Secures Largest Single Order of bluestem™ products

24/01/2019 - 14:30

C$440K Order from Major North American Retailer. WINNIPEG, Manitoba, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is pleased to announced that it [...]

Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

24/01/2019 - 14:01

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical [...]

Trident Brands Inc. Subsidiary Brain Armor® Signs NFL Hall of Famer Randy White as National Brand Ambassador

24/01/2019 - 14:00

Brookfield, WI, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, today announced it has signed NFL Hall of Famer Randy White as National Brand [...]

Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease

24/01/2019 - 14:00

Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, [...]